The National Institutes of Health (NIH) and the U.S. Food and Drug Administration (FDA) have published a new glossary of clinical research terms related to innovative clinical trial design, including studies using real-world data to generate real-world evidence. This glossary is intended to facilitate communication within the clinical research community by establishing a common vocabulary.

The glossary can be viewed here. In addition, leaders from both NIH and FDA have authored an article published in JAMA Network Open that describes the joint agency effort.

Questions can be sent to [email protected]